Quadcap Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.13M Buy
18,578
+6,824
+58% +$398K 0.13% 149
2025
Q4
$634K Sell
11,754
-621
-5% -$29.9K 0.07% 225
2025
Q3
$558K Sell
12,375
-209
-2% -$9.76K 0.07% 246
2025
Q2
$582K Sell
12,584
-773
-6% -$37.9K 0.07% 233
2025
Q1
$815K Sell
13,357
-6,228
-32% -$363K 0.12% 161
2024
Q4
$1.11M Buy
19,585
+5,742
+41% +$321K 0.16% 121
2024
Q3
$716K Sell
13,843
-771
-5% -$36.2K 0.11% 190
2024
Q2
$607K Sell
14,614
-236
-2% -$10.6K 0.11% 206
2024
Q1
$805K Sell
14,850
-1,995
-12% -$102K 0.18% 129
2023
Q4
$864K Buy
+16,845
New +$884K 0.22% 123

Other funds holding BMY

Quadcap Wealth Management's BMY Position: Q1 2026 in Review

Quadcap Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 58% in Q1 2026, buying an estimated $398K and bringing the position to 18,578 shares worth $1.13M. The position accounts for 0.13% of the portfolio, ranked #149.

Quadcap Wealth Management first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Quadcap Wealth Management held 18,578 shares of Bristol-Myers Squibb worth $1.13M as of Q1 2026.
  • Quadcap Wealth Management bought 6,824 Bristol-Myers Squibb shares in Q1 2026, an estimated $398K.
  • Bristol-Myers Squibb made up 0.13% of Quadcap Wealth Management's portfolio in Q1 2026, its #149 holding.
  • Quadcap Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Quadcap Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.